In the distant future, scientists may have invented a new way to cure a disease that has ravaged human society for centuries.

For the past few years, scientists around the world have been working on a technique that involves injecting a chemical that is believed to induce the growth of cancerous cells in the body.

This is a major breakthrough in the treatment of cancer and its related diseases because the chemical is produced naturally, which means it could potentially be used in a number of different ways, such as treating cancers in the skin, the lungs, the brain, and other organs.

However, this is also where things get really interesting.

According to a study by researchers from the University of Pittsburgh, a new type of chemical is being used to cure the disease in humans.

This new compound, known as the “drayal physical therapy” or “dPS” for short, has a unique ability to cause cancer cells to grow and die.

It is, as the name suggests, a type of physical therapy that uses plasma and chemicals to promote growth of cells.

Drayal phys is very similar to the physical therapy found in physical therapy, and its effects are similar.

However, the drug was discovered in a lab in Pittsburgh, which allowed researchers to isolate it, and make it available to the public.

This allows people around the globe to try it out, as it’s still in its early stages and the researchers have only recently been able to produce a clinical trial.DPS has the ability to directly stimulate cancer cells, which is why it has been used to treat patients with multiple sclerosis, multiple myeloma, and breast cancer.

The researchers at the University Pittsburgh say that DPS has already been used successfully in cancer treatment trials, and they believe the technology is promising for treating other types of cancer, such to pancreatic, breast, and prostate cancers.

The team says that Drayal Physotherapy is currently being tested in humans and in several clinical trials.

They hope to get it on the market in the next five to 10 years.

The University of Pennsylvania researchers say that the drug is safe, effective, and does not harm the body or the immune system.

They also say that while the drug has been shown to be effective in patients with advanced cancer, the treatment is currently only being tested on a limited number of people.

This has prompted some to question whether or not the therapy is safe for normal, everyday people.

However Dr. Robert Stolz, a cancer researcher and director of the Johns Hopkins University Comprehensive Cancer Center, told Fox News that the therapy has been proven to be safe and effective in animal studies.

He added that it’s a safe drug and not harmful to the body, which makes it a perfect candidate for the treatment.

“I think we have a lot to learn from this study and it really is a wonderful example of how we can move forward from what has been done so far to what will be done in the future,” he said.

Derek Kline, a professor at the Stanford University School of Medicine and director and chairman of the Department of Radiology, says that the results of this study are exciting because the treatment could potentially help people with advanced cancers like melanoma, lung cancer, and Hodgkin’s lymphoma.

“This is an exciting result and it opens the door for a whole new way of treating these cancers,” he told FoxNews.

Stolz also told Fox that while he does not think this drug will be the first in the field of physical therapies, he thinks it will be a big step forward in the overall treatment of diseases like these.

“We think this is going to be a huge breakthrough in treating cancer and we are very excited about that,” he added.